Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure

Neurochemistry International

Volumn 85-86, Issue , 2015, Pages 14-23

  Navarria, Laura ^a   Zaltieri, Michela ^a   Longhena, Francesca ^a   Spillantini, Maria Grazia ^b   Missale, Cristina ^a   Spano, Pierfranco ^a,c   Bellucci, Arianna ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Alpha synuclein; NMDA; NR2B; Rotenone

Indexed keywords

ALPHA SYNUCLEIN; CALCIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; ROTENONE; CALCIUM;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CELL; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; NERVE CELL DEGENERATION; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; ENZYME ACTIVATION; ION TRANSPORT; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ALPHA-SYNUCLEIN; ANIMALS; CALCIUM; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; ION TRANSPORT; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; RECEPTORS, N-METHYL-D-ASPARTATE; ROTENONE;

EID: 84929963243     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2015.03.008     Document Type: Article

References (58)

1. Anichtchik O., Calo L., and Spillantini M.G. Synaptic dysfunction in synucleinopathies CNS Neurol. Disord. Drug Targets 12 2013 1094 1100
2. Astori S., and Luthi A. Synaptic plasticity at intrathalamic connections via CaV3.3 T-type Ca2+ channels and GluN2B-containing NMDA receptors J. Neurosci 33 2013 624 630
3. Bellucci A., Collo G., Sarnico I., Battistin L., Missale C., and Spano P. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation J. Neurochem 106 2008 560 577
4. Bellucci A., Navarria L., Falarti E., Zaltieri M., Bono F., and Collo G. Redistribution of DAT/alpha-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease PLoS ONE 6 2011 e27959
5. Bellucci A., Navarria L., Zaltieri M., Falarti E., Bodei S., and Sigala S. Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson's disease J. Neurochem 116 2011 588 605
6. Borland M.K., Trimmer P.A., Rubinstein J.D., Keeney P.M., Mohanakumar K., and Liu L. Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells Mol. Neurodegener 3 2008 21
7. Bourne J.N., Chirillo M.A., and Harris K.M. Presynaptic ultrastructural plasticity along CA3→CA1 axons during long-term potentiation in mature hippocampus J. Comp. Neurol 521 2013 3898 3912
8. Braak H., Del T.K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease Neurobiol. Aging 24 2003 197 211
9. Brim B.L., Haskell R., Awedikian R., Ellinwood N.M., Jin L., and Kumar A. Memory in aged mice is rescued by enhanced expression of the GluN2B subunit of the NMDA receptor Behav. Brain Res 238 2013 211 226
10. Cao H., Ren W.H., Zhu M.Y., Zhao Z.Q., and Zhang Y.Q. Activation of glycine site and GluN2B subunit of NMDA receptors is necessary for ERK/CREB signaling cascade in rostral anterior cingulate cortex in rats: implications for affective pain Neurosci. Bull 28 2012 77 87
11. Centonze D., Prosperetti C., Barone I., Rossi S., Picconi B., and Tscherter A. NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum Exp. Neurol 202 2 2006 470 479
12. Chaves R.S., Melo T.Q., Martins S.A., and Ferrari M.F. Protein aggregation containing beta-amyloid, alpha-synuclein and hyperphosphorylated tau in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure BMC Neurosci 11 2010 144
13. Chen X.H., Shu S.Y., Liang Z.J., Bao X.M., Chen L.X., and Wu Y.M. [NR2B-pERK1/2-pElk-1 signaling contributes to the avoidance learning and memory of rats] Zhongguo Ying Yong Sheng Li Xue Za Zhi 23 2007 121 125
14. Cheng F., Li X., Li Y., Wang C., Wang T., and Liu G. alpha-Synuclein promotes clathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death J. Neurochem 119 2011 815 825
15. Choo A.M., Geddes-Klein D.M., Hockenberry A., Scarsella D., Mesfin M.N., and Singh P. NR2A and NR2B subunits differentially mediate MAP kinase signaling and mitochondrial morphology following excitotoxic insult Neurochem. Int 60 2012 506 516
16. Chorfa A., Betemps D., Morignat E., Lazizzera C., Hogeveen K., and Andrieu T. Specific pesticide-dependent increases in alpha-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines Toxicol. Sci 133 2013 289 297
17. Costa C., Sgobio C., Siliquini S., Tozzi A., Tantucci M., and Ghiglieri V. Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease Brain 135 2012 1884 1899
18. Difazio M.C., Hollingsworth Z., Young A.B., and Penney J.B. Jr. Glutamate receptors in the substantia nigra of Parkinson's disease brains Neurology 42 1992 402 406
19. Diogenes M.J., Dias R.B., Rombo D.M., Vicente M.H., Maiolino F., and Guerreiro P. Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation J. Neurosci 32 2012 11750 11762
20. Dupuis J.P., Ladepeche L., Seth H., Bard L., Varela J., and Mikasova L. Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses EMBO J. 33 2014 842 861
21. Games D., Seubert P., Rockenstein E., Patrick C., Trejo M., and Ubhi K. Axonopathy in an alpha-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated alpha-synuclein Am. J. Pathol 182 2013 940 953
22. Gan J., Qi C., Mao L.M., and Liu Z. Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease Drug Des. Devel. Ther 8 2014 165 173
23. Garcia-Reitbock P., Anichtchik O., Bellucci A., Iovino M., Ballini C., and Fineberg E. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease Brain 133 2010 2032 2044
24. Garcia-Reitbock P., Anichtchik O., Bellucci A., Iovino M., Ballini C., and Fineberg E. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease Brain 133 2010 2032 2044
25. Gardoni F., Ghiglieri V., Luca M., and Calabresi P. Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease Prog. Brain Res 183 2010 169 182
26. Koch G. Do studies on cortical plasticity provide a rationale for using non-invasive brain stimulation as a treatment for Parkinson's disease patients? Front. Neurol 4 2013 180
27. Krapivinsky G., Krapivinsky L., Manasian Y., Ivanov A., Tyzio R., and Pellegrino C. The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1 Neuron 40 2003 775 784
28. Lee H.J., Choi C., and Lee S.J. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form J. Biol. Chem 277 1 2002 671 678
29. Li Y.J., Yang Q., Zhang K., Guo Y.Y., Li X.B., and Yang L. Cytisine confers neuronal protection against excitotoxic injury by down-regulating GluN2B-containing NMDA receptors Neurotoxicology 34 2013 219 225
30. Liu S.B., and Zhao M.G. Neuroprotective effect of estrogen: role of nonsynaptic NR2B-containing NMDA receptors Brain Res. Bull 93 2013 27 31
31. Meoni P., Bunnemann B.H., Kingsbury A.E., Trist D.G., and Bowery N.G. NMDA NR1 subunit mRNA and glutamate NMDA-sensitive binding are differentially affected in the striatum and pre-frontal cortex of Parkinson's disease patients Neuropharmacology 38 1999 625 633
32. Mirzaei H., Schieler J.L., Rochet J.C., and Regnier F. Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry Anal. Chem 78 7 2006 2422 2431
33. Munhall A.C., Wu Y.N., Belknap J.K., Meshul C.K., and Johnson S.W. NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons Neurotoxicology 33 2012 429 435
34. Nash J.E., Hill M.P., and Brotchie J.M. Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat Exp. Neurol 155 1999 42 48
35. Paille V., Picconi B., Bagetta V., Ghiglieri V., Sgobio C., and Di F.M. Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition J. Neurosci 30 2010 14182 14193
36. Paladini C.A., and Roeper J. Generating bursts (and pauses) in the dopamine midbrain neurons Neuroscience 282C 2014 109 121
37. Paoletti P., Bellone C., and Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease Nat. Rev. Neurosci 14 2013 383 400
38. Park H., Popescu A., and Poo M.M. Essential role of presynaptic NMDA receptors in activity-dependent BDNF secretion and corticostriatal LTP Neuron 84 2014 1009 1022
39. Paul S., and Connor J.A. NR2B-NMDA receptor-mediated increases in intracellular Ca2+ concentration regulate the tyrosine phosphatase, STEP, and ERK MAP kinase signaling J. Neurochem 114 2010 1107 1118
40. Pizzi M., Boroni F., Bianchetti A., Moraitis C., Sarnico I., and Benarese M. Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line Eur. J. Neurosci 16 2002 2342 2350
41. Prasad K., Beach T.G., Hedreen J., and Richfield E.K. Critical role of truncated alpha-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease Brain Pathol 22 2012 811 825
42. Riquelme E., Abarca J., Campusano J.M., and Bustos G. An NR2B-dependent decrease in the expression of trkB receptors precedes the disappearance of dopaminergic cells in substantia Nigra in a rat model of presymptomatic Parkinson's disease Parkinsons Dis 2012 2012 129605
43. Sava A., Formaggio E., Carignani C., Andreetta F., Bettini E., and Griffante C. NMDA-induced ERK signalling is mediated by NR2B subunit in rat cortical neurons and switches from positive to negative depending on stage of development Neuropharmacology 62 2012 925 932
44. Specht C.G., and Schoepfer R. Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice BMC Neurosci 2 2001 11
45. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
46. Stanika R.I., Pivovarova N.B., Brantner C.A., Watts C.A., Winters C.A., and Andrews S.B. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity Proc. Natl. Acad. Sci. U.S.A. 106 2009 9854 9859
47. Steece-Collier K., Chambers L.K., Jaw-Tsai S.S., Menniti F.S., and Greenamyre J.T. Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors Exp. Neurol 163 2000 239 243
48. Tiwari M., Lopez-Cruzan M., Morgan W.W., and Herman B. Loss of caspase-2-dependent apoptosis induces autophagy after mitochondrial oxidative stress in primary cultures of young adult cortical neurons J. Biol. Chem 286 2011 8493 8506
49. Tofaris G.K., Garcia R.P., Humby T., Lambourne S.L., O'Connell M., and Ghetti B. Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders J. Neurosci 26 2006 3942 3950
50. Tofaris G.K., Garcia R.P., Humby T., Lambourne S.L., O'Connell M., and Ghetti B. Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders J. Neurosci 26 2006 3942 3950
51. Ulas J., Weihmuller F.B., Brunner L.C., Joyce J.N., Marshall J.F., and Cotman C.W. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study J. Neurosci 14 1994 6317 6324
52. Vedder L.C., Smith C.C., Flannigan A.E., and McMahon L.L. Estradiol-induced increase in novel object recognition requires hippocampal NR2B-containing NMDA receptors Hippocampus 23 2013 108 115
53. Vizi E.S., Kisfali M., and Lorincz T. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects Brain Res. Bull 93 2013 32 38
54. Wang Q., Li J., Wei X., Liao J., Xu Y., and Lu T. Alterations of NMDA receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats Int. J. Neurosci 124 2014 457 465
55. Wu Y.N., and Johnson S.W. Rotenone reduces Mg2+-dependent block of NMDA currents in substantia nigra dopamine neurons Neurotoxicology 30 2009 320 325
56. Wu Y.N., Martella G., and Johnson S.W. Rotenone enhances N-methyl-D-aspartate currents by activating a tyrosine kinase in rat dopamine neurons Neuroreport 18 2007 1813 1816
57. Yuan Y.H., Yan W.F., Sun J.D., Huang J.Y., Mu Z., and Chen N.H. The molecular mechanism of rotenone-induced α-synuclein aggregation: emphasizing the role of the calcium/GSK3β pathway Toxicol. Lett 233 2 2015 163 171
58. Zhang X.H., Liu S.S., Yi F., Zhuo M., and Li B.M. Delay-dependent impairment of spatial working memory with inhibition of NR2B-containing NMDA receptors in hippocampal CA1 region of rats Mol. Brain 6 2013 13